DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,117 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $476,836,727 | -34.6% | 1,908,492 | -34.7% | 0.64% | -42.7% |
Q1 2024 | $729,472,575 | +77.4% | 2,921,162 | +64.3% | 1.11% | +59.4% |
Q4 2023 | $411,317,894 | -29.6% | 1,777,980 | -24.6% | 0.70% | -41.1% |
Q3 2023 | $584,663,034 | +121.8% | 2,356,562 | +114.6% | 1.18% | +129.9% |
Q2 2023 | $263,541,600 | -25.9% | 1,098,090 | -22.2% | 0.52% | -31.9% |
Q1 2023 | $355,611,298 | +63.0% | 1,410,932 | +71.7% | 0.76% | +54.0% |
Q4 2022 | $218,121,890 | +880.6% | 821,799 | +854.3% | 0.49% | +902.0% |
Q3 2022 | $22,244,000 | +8.9% | 86,115 | +23.7% | 0.05% | +25.6% |
Q1 2022 | $20,424,000 | -81.3% | 69,629 | -79.1% | 0.04% | -80.7% |
Q4 2021 | $109,512,000 | +161.7% | 332,852 | +142.1% | 0.20% | +16.1% |
Q3 2021 | $41,852,000 | -68.2% | 137,471 | -72.0% | 0.17% | -70.8% |
Q2 2021 | $131,725,000 | +328.3% | 490,849 | +259.2% | 0.60% | +322.7% |
Q1 2021 | $30,758,000 | -64.3% | 136,649 | -64.8% | 0.14% | -69.8% |
Q4 2020 | $86,249,000 | +277.4% | 388,258 | +265.8% | 0.47% | +219.9% |
Q3 2020 | $22,855,000 | -59.3% | 106,138 | -66.6% | 0.15% | -62.8% |
Q2 2020 | $56,165,000 | +5762.7% | 317,620 | +4986.8% | 0.39% | +5514.3% |
Q4 2019 | $958,000 | -98.8% | 6,244 | -98.9% | 0.01% | -98.9% |
Q3 2019 | $79,964,000 | +1825.9% | 553,657 | +1805.5% | 0.63% | +1750.0% |
Q2 2019 | $4,152,000 | -86.9% | 29,055 | -87.9% | 0.03% | -77.3% |
Q1 2019 | $31,730,000 | +5351.9% | 240,350 | +4160.0% | 0.15% | +2400.0% |
Q4 2018 | $582,000 | -95.6% | 5,642 | -95.3% | 0.01% | -89.3% |
Q3 2018 | $13,136,000 | +1290.1% | 120,900 | +1162.5% | 0.06% | +300.0% |
Q2 2018 | $945,000 | -41.5% | 9,576 | -45.0% | 0.01% | -79.4% |
Q4 2017 | $1,616,000 | +30.1% | 17,412 | +17.7% | 0.07% | +23.6% |
Q2 2017 | $1,242,000 | -27.0% | 14,788 | -25.2% | 0.06% | -32.9% |
Q1 2017 | $1,701,000 | -98.4% | 19,777 | -98.6% | 0.08% | -88.5% |
Q4 2016 | $107,923,000 | +121.2% | 1,386,477 | +122.8% | 0.71% | +104.6% |
Q3 2016 | $48,789,000 | +838.2% | 622,392 | +1108.8% | 0.35% | +688.6% |
Q2 2016 | $5,200,000 | -6.6% | 51,488 | -12.3% | 0.04% | -18.5% |
Q1 2016 | $5,569,000 | +576.7% | 58,707 | +562.4% | 0.05% | +575.0% |
Q4 2015 | $823,000 | -53.1% | 8,863 | -56.9% | 0.01% | -63.6% |
Q3 2015 | $1,754,000 | -23.8% | 20,583 | -23.4% | 0.02% | -26.7% |
Q2 2015 | $2,301,000 | -93.5% | 26,881 | -93.5% | 0.03% | -93.5% |
Q1 2015 | $35,279,000 | +313.5% | 415,536 | +317.4% | 0.46% | +307.1% |
Q4 2014 | $8,532,000 | -49.3% | 99,553 | -53.4% | 0.11% | -54.4% |
Q2 2014 | $16,814,000 | – | 213,562 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |